CLINICAL_TRIALS
trial_result
· 2018-09-25
Clinical Trial Update: Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066 [Phase 2]
Summary
Phase 2 trial update assessing the effect of carbohydrate in diet and supplements on GI tolerability of LIK066 in obesity.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2018-09-25